BackLipella Pharmaceuticals Overview

Lipella Pharmaceuticals Research & Development

Research & Development expenses for LIPO.

Quarterly R&D Expenses

$720.97M
↓ 31.12% YoY

As of Sep 30, 2025

Annual R&D Expenses (TTM)

$2.51B
↑ 46.65% YoY

Trailing 12 months ending Sep 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin